GYRE Insider Transactions — Page 5
563 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 401–500; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| deBethizy J Donald | President and CEO | 2009-12-15 | Sale | 15,391.0 | $22.28 |
| Bencherif Merouane | VP, Preclinical Research | 2009-12-14 | Sale | 4,967.0 | $22.45 |
| Bencherif Merouane | VP, Preclinical Research | 2009-12-14 | Sale | 6,533.0 | $22.45 |
| Bencherif Merouane | VP, Preclinical Research | 2009-12-14 | Sale | 1,435.0 | $22.44 |
| deBethizy J Donald | President and CEO | 2009-12-14 | Sale | 2,600.0 | $22.44 |
| Musso Alan A | VP, CFO & Treasurer | 2009-12-11 | Sale | 37,223.0 | $21.53 |
| Brennan Jeffrey P | VP - Bus. & Commercial Dev. | 2009-12-11 | Sale | 94,759.0 | $20.9 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | 2009-10-22 | Sale | 6,035.0 | $20.64 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | 2009-10-21 | Sale | 91,898.0 | $21.0 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | 2009-10-20 | Sale | 23,650.0 | $21.4 |
| Brennan Jeffrey P | VP - Bus. & Commercial Dev. | 2009-10-20 | Sale | 13,978.0 | $21.95 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | 2009-10-19 | Sale | 5,800.0 | $22.68 |
| Brennan Jeffrey P | VP - Bus. & Commercial Dev. | 2009-10-19 | Sale | 5,800.0 | $22.68 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-10-16 | Sale | 374,000.0 | $23.6 |
| BVF PARTNERS L P/IL | TenPercentOwnerOther | 2009-10-16 | Sale | 374,000.0 | $23.6 |
| BVF INC/IL | TenPercentOwnerOther | 2009-10-16 | Sale | 374,000.0 | $23.6 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-10-16 | Sale | 374,000.0 | $23.6 |
| BVF INVESTMENTS LLC | Other | 2009-10-16 | Sale | 374,000.0 | $23.6 |
| LAMPERT MARK N | TenPercentOwnerOther | 2009-10-16 | Sale | 374,000.0 | $23.6 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-10-16 | Sale | 108,000.0 | $23.6 |
| BVF PARTNERS L P/IL | TenPercentOwnerOther | 2009-10-16 | Sale | 108,000.0 | $23.6 |
| BVF INC/IL | TenPercentOwnerOther | 2009-10-16 | Sale | 108,000.0 | $23.6 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-10-16 | Sale | 108,000.0 | $23.6 |
| BVF INVESTMENTS LLC | Other | 2009-10-16 | Sale | 108,000.0 | $23.6 |
| LAMPERT MARK N | TenPercentOwnerOther | 2009-10-16 | Sale | 108,000.0 | $23.6 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-10-16 | Sale | 156,400.0 | $23.6 |
| BVF PARTNERS L P/IL | TenPercentOwnerOther | 2009-10-16 | Sale | 156,400.0 | $23.6 |
| BVF INC/IL | TenPercentOwnerOther | 2009-10-16 | Sale | 156,400.0 | $23.6 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-10-16 | Sale | 156,400.0 | $23.6 |
| BVF INVESTMENTS LLC | Other | 2009-10-16 | Sale | 156,400.0 | $23.6 |
| LAMPERT MARK N | TenPercentOwnerOther | 2009-10-16 | Sale | 156,400.0 | $23.6 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | 2009-09-18 | Sale | 11,000.0 | $17.19 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | 2009-09-16 | Sale | 9,050.0 | $16.27 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | 2009-09-15 | Sale | 950.0 | $16.01 |
| deBethizy J Donald | President and CEO | 2009-09-08 | Sale | 851.0 | $15.0 |
| deBethizy J Donald | President and CEO | 2009-09-04 | Sale | 11,149.0 | $15.02 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | 2009-09-04 | Sale | 10,000.0 | $15.02 |
| Musso Alan A | VP, CFO & Treasurer | 2009-09-04 | Sale | 8,000.0 | $15.07 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-09-04 | Sale | 2,100.0 | $15.07 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-31 | Sale | 13,955.0 | $14.54 |
| deBethizy J Donald | President and CEO | 2009-08-31 | Sale | 9,400.0 | $14.54 |
| Musso Alan A | VP, CFO & Treasurer | 2009-08-31 | Sale | 5,400.0 | $14.5 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-28 | Sale | 5,900.0 | $14.5 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-28 | Sale | 500.0 | $14.08 |
| deBethizy J Donald | President and CEO | 2009-08-28 | Sale | 600.0 | $14.5 |
| Musso Alan A | VP, CFO & Treasurer | 2009-08-28 | Sale | 600.0 | $14.5 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | 2009-08-28 | Sale | 7,900.0 | $14.04 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-28 | Sale | 4,900.0 | $14.5 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-28 | Sale | 500.0 | $14.08 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-27 | Sale | 1,600.0 | $14.0 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-27 | Sale | 1,600.0 | $14.0 |
| deBethizy J Donald | President and CEO | 2009-08-24 | Sale | 2,400.0 | $13.52 |
| Musso Alan A | VP, CFO & Treasurer | 2009-08-24 | Sale | 2,500.0 | $13.55 |
| deBethizy J Donald | President and CEO | 2009-08-14 | Sale | 4,600.0 | $13.51 |
| Musso Alan A | VP, CFO & Treasurer | 2009-08-14 | Sale | 4,500.0 | $13.51 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-11 | Sale | 6,780.0 | $12.69 |
| Brennan Jeffrey P | VP - Bus. & Commercial Dev. | 2009-08-10 | Sale | 15,000.0 | $12.63 |
| deBethizy J Donald | President and CEO | 2009-08-07 | Sale | 2,850.0 | $12.04 |
| deBethizy J Donald | President and CEO | 2009-08-07 | Sale | 2,850.0 | $12.02 |
| Musso Alan A | VP, CFO & Treasurer | 2009-08-07 | Sale | 2,850.0 | $12.04 |
| Musso Alan A | VP, CFO & Treasurer | 2009-08-07 | Sale | 2,850.0 | $12.02 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-07 | Sale | 200.0 | $12.04 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-07 | Sale | 200.0 | $12.02 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-08-07 | Sale | 371.0 | $12.0 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-07-30 | Sale | 636.0 | $12.0 |
| Caldwell William S | VP - Drug Discovery and Dev. | 2009-07-29 | Sale | 693.0 | $12.0 |
| deBethizy J Donald | President and CEO | 2009-07-29 | Sale | 1,300.0 | $12.0 |
| deBethizy J Donald | President and CEO | 2009-07-29 | Sale | 4,400.0 | $11.05 |
| Musso Alan A | VP, CFO & Treasurer | 2009-07-29 | Sale | 1,300.0 | $12.0 |
| Musso Alan A | VP, CFO & Treasurer | 2009-07-29 | Sale | 3,963.0 | $11.05 |
| Bencherif Merouane | VP, Preclinical Research | 2009-07-28 | Sale | 41,213.0 | $10.39 |
| Musso Alan A | VP, CFO & Treasurer | 2009-07-28 | Sale | 3,037.0 | $11.02 |
| deBethizy J Donald | President and CEO | 2009-07-28 | Sale | 2,600.0 | $11.01 |
| Bencherif Merouane | VP, Preclinical Research | 2009-07-27 | Sale | 42,271.0 | $10.14 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-07-14 | Purchase | 6,000.0 | $2.99 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2009-07-14 | Purchase | 6,000.0 | $2.99 |
| BVF INC/IL | TenPercentOwner | 2009-07-14 | Purchase | 6,000.0 | $2.99 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-07-14 | Purchase | 6,000.0 | $2.99 |
| BVF INVESTMENTS LLC | Other | 2009-07-14 | Purchase | 6,000.0 | $2.99 |
| LAMPERT MARK N | TenPercentOwner | 2009-07-14 | Purchase | 6,000.0 | $2.99 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-07-14 | Purchase | 2,000.0 | $2.99 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2009-07-14 | Purchase | 2,000.0 | $2.99 |
| BVF INC/IL | TenPercentOwner | 2009-07-14 | Purchase | 2,000.0 | $2.99 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-07-14 | Purchase | 2,000.0 | $2.99 |
| BVF INVESTMENTS LLC | Other | 2009-07-14 | Purchase | 2,000.0 | $2.99 |
| LAMPERT MARK N | TenPercentOwner | 2009-07-14 | Purchase | 2,000.0 | $2.99 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-07-14 | Purchase | 1,516.0 | $2.99 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2009-07-14 | Purchase | 1,516.0 | $2.99 |
| BVF INC/IL | TenPercentOwner | 2009-07-14 | Purchase | 1,516.0 | $2.99 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-07-14 | Purchase | 1,516.0 | $2.99 |
| BVF INVESTMENTS LLC | Other | 2009-07-14 | Purchase | 1,516.0 | $2.99 |
| LAMPERT MARK N | TenPercentOwner | 2009-07-14 | Purchase | 1,516.0 | $2.99 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-07-13 | Purchase | 1,000.0 | $2.89 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2009-07-13 | Purchase | 1,000.0 | $2.89 |
| BVF INC/IL | TenPercentOwner | 2009-07-13 | Purchase | 1,000.0 | $2.89 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2009-07-13 | Purchase | 1,000.0 | $2.89 |
| BVF INVESTMENTS LLC | Other | 2009-07-13 | Purchase | 1,000.0 | $2.89 |
| LAMPERT MARK N | TenPercentOwner | 2009-07-13 | Purchase | 1,000.0 | $2.89 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2009-07-13 | Purchase | 1,200.0 | $2.89 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2009-07-13 | Purchase | 1,200.0 | $2.89 |